National Parkinson Foundation and Parkinson’s Disease Foundation complete merger
Author: Almaz OhenePublished: 4 August 2016
Prep: Cook: Serves:
New integrated organisation will be a “formidable and effective force in the fight against Parkinson’s”
Two of the biggest Parkinson’s organisations in the US, the National Parkinson Foundation (NPF) and the Parkinson’s Disease Foundation (PDF), have completed their merger. They will now operate as a new organisation called the Parkinson’s Foundation with offices in New York City and Miami.
John Kozyak, chair of the National Parkinson Foundation, said: “This merger is about the future and we are thrilled to have it completed. Millions of people worldwide are living with Parkinson’s. We owe it to them to move the science and care forward and the merger allows us to do just that even better.
“We are driven by the perspective, needs and priorities of people living with the disease and, together, we will be a formidable and effective force in the fight against Parkinson’s.”
The Parkinson’s Foundation has outlined the following three new focus areas:
1. Seeking a cure: We support promising scientific research by investing in individual and collaborative research and training projects as well as in an extensive network of research and medical centres in the United States and around the world.
2. Providing care and support: Until there is a cure, we remain focused on the care and wellbeing of people living with Parkinson’s today. This has always been, and remains, a hallmark of our leading research and educational work.
3. Championing a better future: To do all this, we will expand our advocacy and community outreach efforts to ensure that the response to this disease matches the urgent need.
Dr Michael Okun, co-administrator, Center for Movement Disorders and Neurorestoration and NPF board member, said: “This merger will join two giants in the field, expanding the centre of excellence network, and enhancing the potential ability to fund more research in Parkinson’s disease.
“The NPF and PDF have both been premier organisations with amazing services for patients and families with Parkinson’s disease. The merger will synergise efforts and hopefully bring increased services to the community.”
About the National Parkinson Foundation
The National Parkinson Foundation was founded in 1957 by Jeanne C Levey, whose husband had the condition. Levey worked at the foundation until her death in 1979. Since 1982, the foundation has funded more than $189 million in care, research and support services. It has networks in the US, Canada and also internationally.
About the Parkinson’s Disease Foundation
Founded in 1957 by William Beck, the PDF has funded more than $115 million worth of scientific research in Parkinson’s disease, as well as nearly $50 million in education and advocacy programs. The PDF primarily funded scientific research to find the causes of and a cure for Parkinson’s. It also offers educational programmes and support services for people living with the condition and their loved ones.
Our second episode on deep brain stimulation for Parkinson’s disease
4 days ago
Study suggests why neurons die in Parkinson’s disease
Researchers at the University of Córdoba, Spain, have discovered how a certain protein may be linked to death of dopamine-producing neurons associated with Parkinson’s. Using animal models of the condition to conduct their study, the team focused on the protein DJ-1 – whose link to Parkinson’s has previously been established, though its exact function was uncertain. The researchers compared neurons in the brains of mice that possessed the gene expressing DJ-1 with those that did not. The findings revealed that dysfunction or absence of the gene expressing the DJ-1 protein could trigger the ‘cell cycle’ (the process by which cells divide), which should not occur under normal conditions. Because neurons lack the capacity to divide, this causes them die – leading to the onset of symptoms linked with Parkinson’s. It is hoped that uncovering these details about the relationship between DJ-1’s absence and Parkinson’s may lead to the development of…
Researchers have finally identified brain cells linked to Parkinson’s disease
For decades, scientists have known that Parkinson’s is associated with the death of dopamine-producing cells in the brain. Now, researchers from the Broad Institute of MIT and Harvard, US, have discovered the specific subtype of brain cells that die in Parkinson’s disease. Using a technique called single-cell RNA signalling, which enables the individual analysis of cells within a tissue for activity and protein production, researchers identified 10 subtypes of dopamine-producing cells within the donated brains of people who died from causes unrelated to Parkinson’s. The team carried out the same investigation on people who had died with Parkinson’s or a condition with similar symptoms called Lewy body dementia. They discovered that only one subtype of the cells had reduced in number – which suggests many of these cells had died while the people were living. It is hoped that the findings could lead to better understanding of Parkinson’s causes and…
Tiny DBS implant shows potential to advance Parkinson’s disease treatment
In an innovative trial by North Bristol NHS Trust, UK, surgeons have succeeded in implanting a tiny deep brain stimulation (DBS) device into a person’s skull. Their aim? To address symptoms of Parkinson’s. Designed with a tiny battery system that is inserted into the skull, the DBS device delivers electric impulses to targeted areas of the brain through electric probes. In doing so, it works to address abnormal brain cell activity associated with Parkinson’s – and may help to ease symptoms. One of around 25 patients selected for the year-long trial has described the device’s impact as “amazing”. Commenting on the results of the trial so far, consultant neurologist Dr Alan Whone of North Bristol NHS Trust said: “We are hopeful that if these findings hold up, we will have a significant technical advance by which to improve Parkinson’s care across the world.”